PA-19-054 - NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Required)
is used for the submission of applications to the following Notices of Special Interest (NOSIs)
Active NOSIs
Title |
Notice Number |
Organization |
Release Date |
Expiration Date |
Activity Code(s) |
Expired NOSIs
Title |
Notice Number |
Organization |
Release Date |
Expiration Date |
Activity Code(s) |
Notice of Special Interest: NCCIH High Priority Pain Research |
NOT-AT-22-007 |
NCCIH
|
Dec 20, 2021 |
Dec 15, 2022
|
R01, R21, R15, R34 |
Notice of Special Interest (NOSI): Cannabis, Prescription Opioid, or Prescription Benzodiazepine Drug Use Among Older Adults |
NOT-DA-20-014 |
NIDA
|
Apr 22, 2020 |
Sep 8, 2023
|
R01, R03, R21 |
Notice of Special Interest (NOSI): Single-Cell Proteomics for Interrogating Premalignant and Early Malignant Lesions |
NOT-CA-20-044 |
NCI
|
Apr 9, 2020 |
May 8, 2023
|
R03, R21, R01, P01 |
Notice of Special Interest (NOSI):Sleep and Substance Use Disorders |
NOT-DA-20-021 |
NIDA
|
Mar 25, 2020 |
Sep 8, 2023
|
R01, R03, R21, K99/R00, R61/R33 |
Notice of Special Interest (NOSI): Competitive Revisions for Firearms Injury and Mortality Prevention Research |
NOT-OD-20-089 |
OBSSR NIA NICHD NIMH NCCIH ODP NIMHD ORWH NIAAA
|
Mar 20, 2020 |
May 16, 2020
|
R01, R21 |
Notice of Special Interest (NOSI): Advancing Head and Neck Cancer Early Detection Research (AHEAD) |
NOT-CA-20-031 |
NCI NIDCR
|
Mar 10, 2020 |
Jan 8, 2022
|
R03, R21, R01 |
Notice of Special Interest (NOSI): Effects of Cannabis Use and Cannabinoids on the Developing Brain |
NOT-DA-20-039 |
NIDA
|
Mar 5, 2020 |
Sep 8, 2023
|
R01, R03, R21 |
Notice of Special Interest (NOSI): Mechanistic Investigations of Psychosocial Factors Associated with Substance Use Disorders |
NOT-DA-20-005 |
NIDA
|
Mar 3, 2020 |
Sep 8, 2023
|
R01, R21 |
Notice of Special Interest (NOSI): Drug-drug interactions among substances of abuse, medications to treat HIV infection, and pharmacotherapies to treat substance use disorders |
NOT-DA-20-013 |
NIDA
|
Feb 6, 2020 |
May 8, 2022
|
R01, R03, R21 |
Notice of Special Interest (NOSI): Preclinical and Clinical Studies of the Interactions of Opioids and Stimulants |
NOT-DA-20-007 |
NIDA
|
Jan 6, 2020 |
Jun 5, 2023
|
R03, R21, R01 |
Notice of Special Interest (NOSI): Modeling Social Contagion of Substance Use Epidemics |
NOT-DA-20-009 |
NIDA
|
Jan 2, 2020 |
Jan 8, 2023
|
R01, R03, R21 |
Notice of Special Interest: Exploring the Mechanisms Underlying Analgesic Properties of Minor Cannabinoids and Terpenes |
NOT-AT-20-002 |
NCCIH
|
Dec 13, 2019 |
Jan 8, 2022
|
R01, R21 |
Notice of Special Interest (NOSI): Epidemiology of Drug Abuse |
NOT-DA-19-066 |
NIDA
|
Aug 29, 2019 |
Jan 8, 2022
|
R01, R21, R03, 333 |
Notice of Special Interest (NOSI): Public Health Research on Cannabis |
NOT-DA-19-065 |
NIDA
|
Aug 14, 2019 |
Jan 8, 2022
|
R01, R21, R03, 333 |
Notice of Special Interest (NOSI): The Application of Big Data Analytics to Drug Abuse Research |
NOT-DA-19-041 |
NIDA
|
Jul 12, 2019 |
Jan 8, 2022
|
R01, R21, R03 |
Notice of Special Interest (NOSI): Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Use Disorders (R01, R21, R03) |
NOT-DA-19-037 |
NIDA
|
Jul 11, 2019 |
Sep 8, 2022
|
R01, R21, R03 |
Notice of Special Interest (NOSI): Research to Prevent Drug Use, Misuse and Addiction |
NOT-DA-19-048 |
NIDA
|
Jul 10, 2019 |
Jan 8, 2022
|
R01, R21, R03 |
Notice of Special Interest (NOSI): Gene-Environment Interplay in Substance Use Disorders (R01, R21) |
NOT-DA-19-038 |
NIDA
|
Jul 10, 2019 |
Jan 8, 2022
|
R01, R21 |
Notice of Availability of Competitive Supplements/Revisions for the INCLUDE (Investigation of Co-occurring Conditions across the Lifespan to Understand Down syndromE) Project (Competitive Supplement/Revision Clinical Trial Optional) |
NOT-OD-19-071 |
NIH
|
Feb 5, 2019 |
Mar 17, 2019
|
R01, R03, R21, U01 |
|